Unknown Status NA Interventional 1-arm NCT03715855

Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples (OLFADIAG)

Demonstrating the Diagnostic Power of an Electronic Nose: Pilot Study on Exhaled Air Samples

Sponsor: University Hospital, Montpellier

Conditions Alzheimer Disease Gastric Cancer Pneumological Cancer Urologic Cancer

Interventions olfactory measuring device

Updated 3 times since 2018 Last updated: Oct 22, 2018 Started: Oct 31, 2018 Primary completion: Apr 30, 2020 Completion: Oct 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Alzheimer Disease and Gastric Cancer, this trial is ongoing. The trial is conducted by University Hospital, Montpellier and has accumulated 3 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

3 versions recorded

Jan 2021 — Present [monthly]

Unknown Status NA
Nov 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Nov 2018 — Nov 2020 [monthly]

Not Yet Recruiting NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Montpellier

Data source: University Hospital, Montpellier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.